(2S)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid has been researched along with tolbutamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dan, K; Fukuma, M; Kumashiro, I; Nishikawa, M; Sato, Y; Seto, Y; Shinkai, H; Toi, K; Toyoshima, S | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
2 other study(ies) available for (2S)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid and tolbutamide
| Article | Year |
|---|---|
N-(cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2.
Topics: Administration, Oral; Animals; Blood Glucose; Chemical Phenomena; Chemistry; Cyclohexanes; Dogs; Hypoglycemic Agents; Magnetic Resonance Spectroscopy; Male; Mice; Molecular Conformation; Nateglinide; Phenylalanine | 1989 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |